Wolanskyj AP - Search Results

1

Antiphospholipid antibody-associated chorea.

Orzechowski NM, Wolanskyj AP, Ahlskog JE, Kumar N, Moder KG. Orzechowski NM, et al. Among authors: wolanskyj ap. J Rheumatol. 2008 Nov;35(11):2165-70. doi: 10.3899/jrheum.080268. Epub 2008 Oct 15. J Rheumatol. 2008. PMID: 18925689

2

Estrogen-based hormone therapy and thrombosis risk in women with essential thrombocythemia.

Gangat N, Wolanskyj AP, Schwager SM, Mesa RA, Tefferi A. Gangat N, et al. Among authors: wolanskyj ap. Cancer. 2006 Jun 1;106(11):2406-11. doi: 10.1002/cncr.21891. Cancer. 2006. PMID: 16628652 Free article.

3

Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients.

Gangat N, Wolanskyj AP, McClure RF, Li CY, Schwager S, Wu W, Tefferi A. Gangat N, et al. Among authors: wolanskyj ap. Leukemia. 2007 Feb;21(2):270-6. doi: 10.1038/sj.leu.2404500. Epub 2006 Dec 14. Leukemia. 2007. PMID: 17170720

4

Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera.

Gangat N, Wolanskyj AP, Schwager SM, Hanson CA, Tefferi A. Gangat N, et al. Among authors: wolanskyj ap. Cancer. 2009 Dec 15;115(24):5740-5. doi: 10.1002/cncr.24664. Cancer. 2009. PMID: 19806641 Free article.

5

Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide.

Tefferi A, Szuber N, Vallapureddy RR, Begna KH, Patnaik MM, Elliott MA, Christopher Hook C, Wolanskyj AP, Hanson CA, Ketterling RP, Pardanani A, Gangat N. Tefferi A, et al. Among authors: wolanskyj ap. Am J Hematol. 2019 Jan;94(1):5-9. doi: 10.1002/ajh.25294. Epub 2018 Oct 17. Am J Hematol. 2019. PMID: 30252953 Free article.

6

JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance.

Wolanskyj AP, Lasho TL, Schwager SM, McClure RF, Wadleigh M, Lee SJ, Gilliland DG, Tefferi A. Wolanskyj AP, et al. Br J Haematol. 2005 Oct;131(2):208-13. doi: 10.1111/j.1365-2141.2005.05764.x. Br J Haematol. 2005. PMID: 16197451 Free article.

7

Abdominal vein thrombosis in essential thrombocythemia: prevalence, clinical correlates, and prognostic implications.

Gangat N, Wolanskyj AP, Tefferi A. Gangat N, et al. Among authors: wolanskyj ap. Eur J Haematol. 2006 Oct;77(4):327-33. doi: 10.1111/j.1600-0609.2006.00715.x. Epub 2006 Jul 19. Eur J Haematol. 2006. PMID: 16856928

8

Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance.

Gangat N, Tefferi A, Thanarajasingam G, Patnaik M, Schwager S, Ketterling R, Wolanskyj AP. Gangat N, et al. Among authors: wolanskyj ap. Eur J Haematol. 2009 Jul;83(1):17-21. doi: 10.1111/j.1600-0609.2009.01246.x. Epub 2009 Feb 19. Eur J Haematol. 2009. PMID: 19236446

9

Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies.

Gangat N, Wolanskyj AP, Schwager S, Tefferi A. Gangat N, et al. Among authors: wolanskyj ap. Eur J Haematol. 2009 May;82(5):350-3. doi: 10.1111/j.1600-0609.2009.01214.x. Epub 2009 Jan 6. Eur J Haematol. 2009. PMID: 19243425

10

Lack of efficacy of pyridoxine (vitamin B6) treatment in acquired idiopathic sideroblastic anaemia, including refractory anaemia with ring sideroblasts.

Baumann Kreuziger LM, Wolanskyj AP, Hanson CA, Steensma DP. Baumann Kreuziger LM, et al. Among authors: wolanskyj ap. Eur J Haematol. 2011 Jun;86(6):512-6. doi: 10.1111/j.1600-0609.2011.01604.x. Epub 2011 Apr 1. Eur J Haematol. 2011. PMID: 21388451

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page